Amir F. Ayyobi - Concepedia

Author

Amir F. Ayyobi

University of British Columbia

Also Known As

A. Ayyobi, A.F Ayyobi, A.F. Ayyobi, Amir Ayyobi, Amir F Ayyobi, Amir F. Ayyobi, Ayyobi, Amir Fardad

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia St. Paul's Hospital Amsterdam UMC Location University of Amsterdam University of Washington

About

Amir F. Ayyobi is an author at University of British Columbia specializing in medicine, metabolic syndrome, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	191
2	Engineering	1	1	11
3	Public Health	1	1	83
4	Biochemistry	1	1	11
5	Biomolecular Engineering	1	1	11

Amir F. Ayyobi

Publications

745

Citations

H-Index

Page 1

	Year	Citations
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition Fränzel J.B. van Duijnhoven, H. Bas Bueno‐de‐Mesquita, Miriam Calligaro, Gut	2011	231
Small, Dense LDL and Elevated Apolipoprotein B Are the Common Characteristics for the Three Major Lipid Phenotypes of Familial Combined Hyperlipidemia Amir F. Ayyobi, Sandra H. McGladdery, Marguerite J. McNeely, Arteriosclerosis Thrombosis and Vascular Biology	2003	103
Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women Molly C. Carr, Amir F. Ayyobi, Susan J. Murdoch, Arteriosclerosis Thrombosis and Vascular Biology	2002	100
Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up Amir F. Ayyobi, Sandra H. McGladdery, Sammy Chan, Atherosclerosis Metabolic SyndromeVascular DiseaseCardiovascular DiseasePathologyCholesterol Acyltransferase	2004	85
APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease Kenny W.J. Lee, Amir F. Ayyobi, Jiří Fröhlich, Atherosclerosis Metabolic SyndromeApoa5 Gene PolymorphismCardiovascular DiseaseGeneticsGenetic Epidemiology	2004	83
Response to micronized fenofibrate treatment is associated with the peroxisome???proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes Christelle Foucher, Stephanie Rattier, David M. Flavell, Pharmacogenetics	2004	47
Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and white patients with acute myocardial infarction: administrative data analysis Danijela Gašević, Nadia Khan, Hong Qian, BMC Cardiovascular Disorders	2013	39
Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene Jonas Peterson, Amir F. Ayyobi, Yuanhong Ma, Journal of Lipid Research	2002	34
Cholesterol ester transfer protein (CETP) Taq1B polymorphism influences the effect of a standardized cardiac rehabilitation program on lipid risk markers Amir F. Ayyobi, John S. Hill, Henri O.F. Molhuizen, Atherosclerosis Metabolic SyndromeCardiovascular DiseaseAtherosclerosisLipid Risk MarkersHyperlipidemia	2005	12
Biochemical and compositional analyses of recombinant lecithin:cholesterol acyltransferase (LCAT) obtained from a hepatic source Amir F. Ayyobi, Andras G. Lacko, Karen Riva Murray, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids Lipid AnalysisBiosynthesisEngineeringLipid SynthesisBiochemistry	2000	11

Page 1